Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Inventory: 2009-2025

Historic Change in Inventory for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to -$57,779.

  • China Pharma Holdings' Change in Inventory rose 84.66% to -$57,779 in Q3 2025 from the same period last year, while for Sep 2025 it was -$890,206, marking a year-over-year increase of 34.28%. This contributed to the annual value of -$1.6 million for FY2024, which is 9520.14% down from last year.
  • Per China Pharma Holdings' latest filing, its Change in Inventory stood at -$57,779 for Q3 2025, which was up 64.94% from -$164,804 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Change in Inventory ranged from a high of $552,686 in Q1 2023 and a low of -$679,042 during Q2 2021.
  • For the 3-year period, China Pharma Holdings' Change in Inventory averaged around -$179,004, with its median value being -$164,804 (2025).
  • Its Change in Inventory has fluctuated over the past 5 years, first slumped by 6,335.20% in 2021, then skyrocketed by 311.81% in 2022.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Change in Inventory stood at -$255,815 in 2021, then grew by 24.59% to -$192,902 in 2022, then crashed by 34.09% to -$258,659 in 2023, then plummeted by 97.56% to -$510,996 in 2024, then soared by 84.66% to -$57,779 in 2025.
  • Its last three reported values are -$57,779 in Q3 2025, -$164,804 for Q2 2025, and -$156,627 during Q1 2025.